他莫西芬联合孕三烯酮预防子宫内膜异位症术后复发的疗效观察

doi:10.3969/j.issn.1671-7171.2020.01.012

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To explore the clinical effect of tamoxifen combined with gestrinone in the prevention of postoperative recurrence of endometriosis.【Methods】From January 2016 to January 2017, 86 patients with endometriosis who were treated in Taikang Xianlin Gulou Hospital and Huaiyin Hospital of Huai'an City, Jiangsu Province were randomly divided into the observation group and the control group according to the random number table method. The control group was treated with gestrinone, and the observation group was treated with tamoxifen on the basis of the control group. The clinical effect, immune function, estrogen (E₂) and follicle stimulating hormone (FSH) were compared between the two groups. 【Results】The total effective rate of the observation group was significantly higher than that of the control group (97.7% vs 83.7%), and the recurrence rate was lower than that of the control group (2.32% vs 16.28%). The difference was statistically significant [χ² (effective)=5.109,P=0.024;χ²(recurrence) = 4.962, P=0.026]. Before treatment, there was no significant difference in immune function indexes and hormone levels between the two groups (P> 0.05); after treatment, the levels of CD4⁺ CD8⁺ CD4⁺/CD8⁺ in the two groups were increased, and the increase was more obvious in the observation group (P<0.05); the levels of E₂ and FSH were decreased, and the decrease was more obvious in the observation group, and the difference was statistically significant (P<0.05). The incidence of adverse reactions in the observation group was 2.3% (1/43), which was significantly lower than that in the control group 20.9% (9/43), and the difference was statistically significant (P<0.05).【Conclusion】Tamoxifen combined with gestrinone can prevent the recurrence of endometriosis after operation. It has a significant effect, improves the immune function and hormone level of patients, and has a high safety. It is worthy of clinical application.

Key words： Endometriosis/SU Endometriosis/DT Tamoxifen／PD Gestrinone／PD

Received: 04 December 2018

PACS:

R711.71

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YAO Jing
	SUN Jing
	LIU Su-qin

Cite this article:

YAO Jing,SUN Jing,LIU Su-qin. Effect of Tamoxifen Combined with Gestrinone on the Prevention of Postoperative Recurrence of Endometriosis[J]. JOURNAL OF CLINICAL RESEARCH, 2020, 37(1): 36-38.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2020.01.012 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2020/V37/I1/36

[1] 莫锐婷, 张春妮. 促性腺激素释放激素激动剂联合反加疗法对子宫内膜异位症患者激素水平及低雌激素状态的影响研究[J].现代医学, 2018,7(3) :192-195.
[2] Laliscia C , Delishaj D , Fabrini MG . Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer is local therapy with hyaluronic acid of clinical benefit[J].Eur J Cancer,2016, 8(6):512-517.
[3] 张春妮, 莫锐婷, 袁建寰. GnRH-a延长给药间隔周期治疗子宫腺肌病及子宫内膜异位症的疗效[J].热带医学杂志, 2018,12(1):65-68.
[4] 刘国华.子宫内膜异位症的药物治疗进展[J].世界最新医学信息文摘,2017,17(A3):157-158.
[5] 莫颖茵, 陈谊明, 谭桂云, 等. 宫腹腔镜手术联合中医综合疗法治疗女性不孕症的效果[J].广东医学, 2016, 37(S1):230-232.
[6] Romero JM , Trujillo M , Estrin DA,et al.Impact of human galectin-1 binding to saccharide ligands on dimer dissociation kinetics and structure[J].Glycobiology,2016, 26(12):1317-1319.
[7] 宋豪,李慧,黄薇.腹腔镜手术联合孕三烯酮治疗子宫内膜异位症合并不孕的疗效分析[J].华西医学,2011,26(3):382-384.
[8] 梁晓红, 丁金萍. 雷公藤多苷联合孕三烯酮治疗子宫内膜异位症的疗效及对相关血清指标的影响[J].中国妇幼保健, 2017, 32(24):6145-6146.
[9] 王俊岭. 不同剂量孕三烯酮治疗子宫内膜异位症期间不规则子宫出血的影响因素和用药方案优化探讨[J].中国药物警戒, 2017, 14(2):82-86.
[10] 孙秀利.孕三烯酮联合腹腔镜下电凝治疗子宫内膜异位症的临床疗效[J].医学综述, 2016, 22(12):2483-2486.
[11] 周晓红, 傅文君, 王宝娣, 等. 雷公藤多苷联合孕三烯酮对子宫内膜异位症及血清细胞因子表达的临床研究[J].中国中药杂志, 2016, 41(18):3478-3482.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(7): 1388-1390.